PITTSBURGH, March 26 -- Mylan Inc. today announced its plans to purchase the remaining interest in Matrix Laboratories Limited from minority shareholders pursuant to a voluntary delisting offer. Mylan ...
Collagen Matrix Augments Senior Leadership Team Naming Bart J. Doedens as Chief Executive Officer OAKLAND, N.J.--(BUSINESS WIRE)--Collagen Matrix, Inc. ("Collagen Matrix"), a leading provider of ...
PITTSBURGH, March 10, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug ...
Berlin-based delivery specialist TheraKine is developing a technology that it says could ease the local delivery of biological agents and small molecules, including the opioid receptor naltrexone used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback